1. Home
  2. EVF vs CALC Comparison

EVF vs CALC Comparison

Compare EVF & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Senior Income Trust

EVF

Eaton Vance Senior Income Trust

HOLD

Current Price

$5.31

Market Cap

95.9M

Sector

Finance

ML Signal

HOLD

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$5.40

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVF
CALC
Founded
1998
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.9M
88.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EVF
CALC
Price
$5.31
$5.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$16.00
AVG Volume (30 Days)
93.3K
96.2K
Earning Date
01-01-0001
11-12-2025
Dividend Yield
10.68%
N/A
EPS Growth
N/A
N/A
EPS
0.94
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.20
$1.42
52 Week High
$6.84
$7.20

Technical Indicators

Market Signals
Indicator
EVF
CALC
Relative Strength Index (RSI) 45.04 50.30
Support Level $5.25 $5.05
Resistance Level $5.38 $5.71
Average True Range (ATR) 0.04 0.70
MACD 0.00 -0.16
Stochastic Oscillator 36.60 16.74

Price Performance

Historical Comparison
EVF
CALC

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

Share on Social Networks: